Hayim Raclaw
Amministratore Delegato presso PsyTech Global
Profilo
Hayim Raclaw is currently the Chief Executive Officer and Director at PsyTech Global since 2020.
Prior to this, he worked as the Chief Operating Officer at Wesana Health Holdings, Inc.
Posizioni attive di Hayim Raclaw
Società | Posizione | Inizio |
---|---|---|
PsyTech Global
PsyTech Global Packaged SoftwareTechnology Services PsyTech Global is a division of iCAN\: Cannabis that combines a robust psychedelic therapeutic community with integrative mental healthcare delivery and enabling tools for novel modalities of care. The Canadian company is a leader in the development of data-driven tools that allow physicians unprecedented insight into patient well-being and clinical best practices. PsyTech is mainstreaming the adoption of psychedelic-assisted therapies through the promotion and delivery of safe and effective therapy, combating stigma, and accelerating innovation. The company also serves as an events platform and innovation scout for psychedelic medicine. Hayim Raclaw has been the CEO of the company since 2020. | Amministratore Delegato | 01/02/2020 |
Precedenti posizioni note di Hayim Raclaw
Società | Posizione | Fine |
---|---|---|
WESANA HEALTH HOLDINGS INC. | Direttore operativo | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
WESANA HEALTH HOLDINGS INC. | Health Technology |
Aziende private | 1 |
---|---|
PsyTech Global
PsyTech Global Packaged SoftwareTechnology Services PsyTech Global is a division of iCAN\: Cannabis that combines a robust psychedelic therapeutic community with integrative mental healthcare delivery and enabling tools for novel modalities of care. The Canadian company is a leader in the development of data-driven tools that allow physicians unprecedented insight into patient well-being and clinical best practices. PsyTech is mainstreaming the adoption of psychedelic-assisted therapies through the promotion and delivery of safe and effective therapy, combating stigma, and accelerating innovation. The company also serves as an events platform and innovation scout for psychedelic medicine. Hayim Raclaw has been the CEO of the company since 2020. | Technology Services |
- Borsa valori
- Insiders
- Hayim Raclaw